Re: The problem...as I see it
in response to
by
posted on
Oct 16, 2020 05:30PM
I was not aware that physicians were doing so - but I am in the UK not the USA.
I cannot see any justification for prescribing SGLT2 inhibitors to non-diabetics unless a clinical trial has shown it is safe and that it lowers MACE.